<TEXT>&#2;<DATELINE>2015-02-01</DATELINE><TITLE>Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections</TITLE><BODY>The recent Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak poses a serious threat to public health. Here, we summarize recent advances in identifying human neutralizing monoclonal antibodies (mAbs) against MERS-CoV, describe their mechanisms of action, and analyze their potential for treatment of MERS-CoV infections.&#3;</BODY></TEXT>